Home›Companies›Biotech & Pharma›Faeth Therapeutics

Faeth Therapeutics, Inc.

Updated Oct 29, 2026·Latest SEC filing Jan 27, 2026·Suggest an edit

About Faeth Therapeutics

Faeth Therapeutics is a private company based in Austin, Texas. It has reported $24,434,214 raised in one offering on Form D since January 2026. Its chief executive is Anand Parikh.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 1, 2025Jan 27, 2026$24,434,214of $24.9M target35$698KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Faeth Therapeutics's Form D filed Jan 27, 2026.

JD
AP
Anand Parikh
Chief Executive Officer and director
AM
Alex Morgan
Director
RG
Robert Gould
Director
SH
Stephen Hahn
Director
OM
Oliver Maddocks
Executive officer and director

Sources

  1. SECFaeth Therapeutics, Inc. filing history